Microbix Total Current Liabilities vs Total Revenue Analysis

MBX Stock

CAD 0.31 0.01 3.13%

Microbix Biosystems financial indicator trend analysis is infinitely more than just investigating Microbix Biosystems recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Microbix Biosystems is a good investment. Please check the relationship between Microbix Biosystems Total Current Liabilities and its Total Revenue accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Microbix Biosystems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Total Current Liabilities vs Total Revenue

Total Current Liabilities vs Total Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Microbix Biosystems Total Current Liabilities account and Total Revenue. At this time, the significance of the direction appears to have weak relationship.

The correlation between Microbix Biosystems' Total Current Liabilities and Total Revenue is 0.36. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Total Revenue in the same time period over historical financial statements of Microbix Biosystems, assuming nothing else is changed. The correlation between historical values of Microbix Biosystems' Total Current Liabilities and Total Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of Microbix Biosystems are associated (or correlated) with its Total Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Revenue has no effect on the direction of Total Current Liabilities i.e., Microbix Biosystems' Total Current Liabilities and Total Revenue go up and down completely randomly.

Correlation Coefficient

0.36

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Total Current Liabilities

Total Current Liabilities is an item on Microbix Biosystems balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Microbix Biosystems are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Revenue

Total revenue comprises all receipts Microbix Biosystems generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Most indicators from Microbix Biosystems' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Microbix Biosystems current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Microbix Biosystems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

As of the 30th of November 2024, Selling General Administrative is likely to grow to about 7.9 M, while Tax Provision is likely to drop 0.00.

	2021	2022	2023	2024 (projected)
Gross Profit	11.1M	7.5M	8.6M	4.4M
Total Revenue	19.1M	16.5M	19.0M	19.9M

Gross Profit Total Revenue

Microbix Biosystems fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Non Current Liabilities Total	Intangible Assets	Common Stock Total Equity	Common Stock
Total Assets		0.35	0.22	0.39	0.98	0.44	-0.58	-0.47	0.47	0.78	0.32	0.02	0.78	0.91	0.91	0.89	0.72	0.49	0.48	0.98	0.89	-0.18	0.4	0.22	0.71	0.81
Short Long Term Debt Total	0.35		0.27	0.76	0.18	0.8	0.39	-0.69	0.8	-0.13	0.78	0.15	-0.13	0.29	0.38	0.4	-0.26	0.18	0.95	0.42	0.04	0.47	0.79	0.63	0.66	0.47
Other Current Liab	0.22	0.27		0.29	0.17	0.08	-0.09	-0.38	0.14	0.16	0.12	0.26	0.16	0.24	0.29	0.22	0.06	0.41	0.34	0.21	0.2	0.07	0.27	0.13	0.28	0.31
Total Current Liabilities	0.39	0.76	0.29		0.27	0.74	0.28	-0.49	0.72	-0.09	0.75	0.42	-0.09	0.23	0.35	0.54	-0.13	0.52	0.8	0.39	0.09	0.69	0.33	0.59	0.68	0.44
Total Stockholder Equity	0.98	0.18	0.17	0.27		0.33	-0.72	-0.35	0.33	0.87	0.19	-0.02	0.87	0.89	0.87	0.84	0.8	0.48	0.33	0.94	0.93	-0.26	0.27	0.07	0.64	0.8
Property Plant And Equipment Net	0.44	0.8	0.08	0.74	0.33		0.29	-0.38	0.89	-0.09	0.93	0.51	-0.09	0.24	0.29	0.39	-0.19	0.03	0.82	0.53	0.06	0.39	0.6	0.69	0.55	0.41
Net Debt	-0.58	0.39	-0.09	0.28	-0.72	0.29		-0.01	0.24	-0.95	0.48	0.38	-0.95	-0.66	-0.57	-0.42	-0.91	-0.36	0.23	-0.52	-0.87	0.59	0.08	0.55	-0.21	-0.57
Retained Earnings	-0.47	-0.69	-0.38	-0.49	-0.35	-0.38	-0.01		-0.4	-0.21	-0.29	0.24	-0.21	-0.49	-0.72	-0.68	-0.07	-0.58	-0.68	-0.5	-0.37	-0.14	-0.61	-0.15	-0.83	-0.67
Accounts Payable	0.47	0.8	0.14	0.72	0.33	0.89	0.24	-0.4		-0.03	0.86	0.38	-0.03	0.26	0.31	0.42	-0.08	0.08	0.87	0.53	0.11	0.24	0.7	0.71	0.52	0.42
Cash	0.78	-0.13	0.16	-0.09	0.87	-0.09	-0.95	-0.21	-0.03		-0.29	-0.35	1.0	0.84	0.78	0.62	0.93	0.45	0.01	0.74	0.97	-0.5	0.12	-0.38	0.41	0.72
Non Current Assets Total	0.32	0.78	0.12	0.75	0.19	0.93	0.48	-0.29	0.86	-0.29		0.62	-0.29	0.07	0.13	0.31	-0.34	-0.05	0.79	0.36	-0.12	0.47	0.53	0.89	0.44	0.23
Non Currrent Assets Other	0.02	0.15	0.26	0.42	-0.02	0.51	0.38	0.24	0.38	-0.35	0.62		-0.35	-0.28	-0.25	-0.01	-0.36	-0.11	0.19	0.02	-0.3	0.38	-0.08	0.6	-0.08	-0.2
Cash And Short Term Investments	0.78	-0.13	0.16	-0.09	0.87	-0.09	-0.95	-0.21	-0.03	1.0	-0.29	-0.35		0.84	0.78	0.62	0.93	0.45	0.01	0.74	0.97	-0.5	0.12	-0.38	0.41	0.72
Net Receivables	0.91	0.29	0.24	0.23	0.89	0.24	-0.66	-0.49	0.26	0.84	0.07	-0.28	0.84		0.92	0.77	0.8	0.49	0.4	0.91	0.92	-0.26	0.42	-0.02	0.65	0.79
Common Stock Shares Outstanding	0.91	0.38	0.29	0.35	0.87	0.29	-0.57	-0.72	0.31	0.78	0.13	-0.25	0.78	0.92		0.92	0.68	0.67	0.48	0.9	0.89	-0.16	0.43	0.0	0.83	0.88
Inventory	0.89	0.4	0.22	0.54	0.84	0.39	-0.42	-0.68	0.42	0.62	0.31	-0.01	0.62	0.77	0.92		0.58	0.73	0.53	0.84	0.78	-0.02	0.34	0.21	0.87	0.82
Other Current Assets	0.72	-0.26	0.06	-0.13	0.8	-0.19	-0.91	-0.07	-0.08	0.93	-0.34	-0.36	0.93	0.8	0.68	0.58		0.43	-0.07	0.66	0.91	-0.58	0.03	-0.34	0.33	0.6
Other Stockholder Equity	0.49	0.18	0.41	0.52	0.48	0.03	-0.36	-0.58	0.08	0.45	-0.05	-0.11	0.45	0.49	0.67	0.73	0.43		0.28	0.42	0.56	0.19	-0.04	-0.17	0.7	0.61
Total Liab	0.48	0.95	0.34	0.8	0.33	0.82	0.23	-0.68	0.87	0.01	0.79	0.19	0.01	0.4	0.48	0.53	-0.07	0.28		0.54	0.19	0.32	0.83	0.64	0.74	0.6
Property Plant And Equipment Gross	0.98	0.42	0.21	0.39	0.94	0.53	-0.52	-0.5	0.53	0.74	0.36	0.02	0.74	0.91	0.9	0.84	0.66	0.42	0.54		0.85	-0.18	0.5	0.22	0.7	0.8
Total Current Assets	0.89	0.04	0.2	0.09	0.93	0.06	-0.87	-0.37	0.11	0.97	-0.12	-0.3	0.97	0.92	0.89	0.78	0.91	0.56	0.19	0.85		-0.4	0.22	-0.22	0.58	0.81
Short Term Debt	-0.18	0.47	0.07	0.69	-0.26	0.39	0.59	-0.14	0.24	-0.5	0.47	0.38	-0.5	-0.26	-0.16	-0.02	-0.58	0.19	0.32	-0.18	-0.4		-0.16	0.37	0.15	-0.16
Non Current Liabilities Total	0.4	0.79	0.27	0.33	0.27	0.6	0.08	-0.61	0.7	0.12	0.53	-0.08	0.12	0.42	0.43	0.34	0.03	-0.04	0.83	0.5	0.22	-0.16		0.46	0.54	0.56
Intangible Assets	0.22	0.63	0.13	0.59	0.07	0.69	0.55	-0.15	0.71	-0.38	0.89	0.6	-0.38	-0.02	0.0	0.21	-0.34	-0.17	0.64	0.22	-0.22	0.37	0.46		0.24	0.03
Common Stock Total Equity	0.71	0.66	0.28	0.68	0.64	0.55	-0.21	-0.83	0.52	0.41	0.44	-0.08	0.41	0.65	0.83	0.87	0.33	0.7	0.74	0.7	0.58	0.15	0.54	0.24		0.89
Common Stock	0.81	0.47	0.31	0.44	0.8	0.41	-0.57	-0.67	0.42	0.72	0.23	-0.2	0.72	0.79	0.88	0.82	0.6	0.61	0.6	0.8	0.81	-0.16	0.56	0.03	0.89

Click cells to compare fundamentals

Microbix Biosystems Account Relationship Matchups

Microbix Biosystems fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	15.6M	28.8M	33.1M	35.7M	41.0M	43.1M
Short Long Term Debt Total	6.2M	7.7M	5.8M	6.6M	7.6M	4.5M
Other Current Liab	1.5M	1.8M	1.8M	2.0M	2.3M	1.3M
Total Current Liabilities	4.1M	5.2M	2.7M	4.3M	5.0M	2.7M
Total Stockholder Equity	6.6M	18.6M	24.9M	24.6M	28.3M	29.7M
Property Plant And Equipment Net	7.4M	8.1M	8.9M	8.9M	10.3M	5.8M
Net Debt	6.1M	(2.3M)	(7.7M)	(5.0M)	(5.7M)	(5.4M)
Retained Earnings	(41.9M)	(38.7M)	(36.9M)	(36.9M)	(33.2M)	(31.6M)
Accounts Payable	1.5M	1.8M	1.8M	2.1M	2.4M	1.5M
Cash	92.7K	10.0M	13.5M	11.6M	13.3M	14.0M
Non Current Assets Total	9.1M	9.7M	10.7M	13.4M	15.4M	9.0M
Cash And Short Term Investments	92.7K	10.0M	13.5M	11.6M	13.3M	14.0M
Net Receivables	1.9M	4.2M	3.1M	4.2M	4.8M	5.0M
Common Stock Shares Outstanding	104.8M	141.7M	141.7M	137.9M	158.6M	166.5M
Liabilities And Stockholders Equity	15.6M	28.8M	33.1M	35.7M	41.0M	43.1M
Inventory	4.3M	4.4M	5.3M	5.8M	6.6M	6.9M
Other Current Assets	220.1K	495.0K	546.3K	767.5K	882.6K	926.7K
Other Stockholder Equity	13.2M	13.6M	9.6M	10.2M	11.8M	11.5M
Total Liab	9.0M	10.3M	8.2M	11.0M	12.7M	6.5M
Property Plant And Equipment Gross	7.4M	14.7M	16.4M	17.4M	20.0M	21.0M
Total Current Assets	6.5M	19.1M	22.4M	22.3M	25.6M	26.9M
Short Term Debt	1.3M	2.7M	267.4K	265.4K	305.2K	290.0K
Non Current Liabilities Total	4.9M	5.1M	5.6M	6.7M	7.7M	4.0M
Intangible Assets	1.7M	1.7M	1.5M	4.4M	5.1M	3.5M
Common Stock	35.4M	43.6M	49.9M	49.0M	56.4M	35.8M
Current Deferred Revenue	1.3M	742.9K	554.6K	2.0M	2.3M	2.4M
Net Tangible Assets	5.6M	4.9M	16.9M	23.4M	27.0M	28.3M
Long Term Debt	4.5M	4.1M	4.7M	5.7M	5.1M	3.8M
Short Long Term Debt	2.6M	1.1M	2.4M	111.1K	100.0K	95.0K
Property Plant Equipment	6.7M	7.4M	8.1M	8.9M	8.0M	7.4M
Long Term Debt Total	4.3M	4.9M	5.1M	5.6M	6.4M	5.5M
Capital Surpluse	9.4M	10.3M	10.7M	9.6M	11.1M	9.2M
Capital Lease Obligations	541.9K	1.2M	1.0M	854.0K	982.1K	589.3K
Net Invested Capital	12.3M	25.1M	29.8M	30.4M	35.0M	24.1M
Net Working Capital	2.4M	13.9M	19.8M	18.0M	20.6M	21.7M
Capital Stock	35.4M	43.6M	49.9M	49.0M	56.4M	45.1M

Pair Trading with Microbix Biosystems

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Microbix Biosystems position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Microbix Biosystems will appreciate offsetting losses from the drop in the long position's value.

Moving together with Microbix Stock

0.86	THRM	Therma Bright	Pair Corr
0.67	FUND	Katipult Technology Corp	Pair Corr

Moving against Microbix Stock

0.81

BHC

Bausch Health Companies

Pair Corr

The ability to find closely correlated positions to Microbix Biosystems could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microbix Biosystems when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microbix Biosystems - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microbix Biosystems to buy it.

The correlation of Microbix Biosystems is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microbix Biosystems moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microbix Biosystems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Microbix Biosystems can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Other Information on Investing in Microbix Stock

Balance Sheet is a snapshot of the financial position of Microbix Biosystems at a specified time, usually calculated after every quarter, six months, or one year. Microbix Biosystems Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Microbix Biosystems and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Microbix currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Microbix Total Current Liabilities vs Total Revenue Analysis

Total Current Liabilities vs Total Revenue

Total Current Liabilities vs Total Revenue Correlation Analysis

Correlation Coefficient

Total Current Liabilities

Total Revenue

Microbix Biosystems fundamental ratios Correlations

Microbix Biosystems Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Microbix Biosystems fundamental ratios Accounts

Pair Trading with Microbix Biosystems

Moving together with Microbix Stock

Moving against Microbix Stock

Other Information on Investing in Microbix Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Total Stockholder Equity	+ 0.98	Total Assets
Property Plant And Equipment Gross	+ 0.98	Total Assets
Total Current Assets	+ 0.97	Cash
Total Current Assets	+ 0.97	Cash And Short Term Investments
Total Liab	+ 0.95	Short Long Term Debt Total

Cash And Short Term Investments	- 0.95	Net Debt
Cash	- 0.95	Net Debt
Other Current Assets	- 0.91	Net Debt
Total Current Assets	- 0.87	Net Debt
Common Stock Total Equity	- 0.83	Retained Earnings
Common Stock Shares Outstanding	- 0.72	Retained Earnings